Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis

2008318 citationsReviewhybrid Open Access

Authors

Christoph Stettler · Institute of Social and Preventive Medicine

Sabin Allemann · University Hospital of Bern

Simon Wandel · University of Bern

Adnan Kastrati · Deutsches Herzzentrum der Charité

Marie-Claude Morice · Hôpital Privé Jacques Cartier

Albert Schömig · Deutsches Herzzentrum der Charité

M Pfisterer

Abstract

In trials that specified a duration of dual antiplatelet therapy of six months or more after stent implantation, drug eluting stents seemed safe and effective in people both with and without diabetes.

Topics & Keywords

Coronary Interventions and Diagnostics Cerebrovascular and Carotid Artery Diseases Antiplatelet Therapy and Cardiovascular Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ

Volume 337, Issue aug29 3, pp. a1331-a1331

DOI: 10.1136/bmj.a1331

Field-Weighted Citation Impact: 28.57